PharmaCorp Rx (TSXV:PCRX) Inventories, Work In Process: C$0.00 Mil (As of Mar. 2026)


TSXV:PCRX PharmaCorp Rx Inc TSXV:PCRX
36 GF Score
Price C$0.50
! 2 Warning Signs
View Full Analysis

What is PharmaCorp Rx Inventories, Work In Process?

PharmaCorp Rx TSXV:PCRX -3.85% 36 Inventories, Work In Process is C$0.00 Mil as of Mar. 2026. GuruFocus rates TSXV:PCRX with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. PharmaCorp Rx's work in process for the quarter that ended in Mar. 2026 was C$0.00 Mil.

PharmaCorp Rx Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for PharmaCorp Rx's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaCorp Rx Inventories, Work In Process Chart

PharmaCorp Rx Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
0.00 0.00 0.00 0.00 0.00

PharmaCorp Rx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSXV:PCRX
36GF Score
PharmaCorp Rx Inc TSXV:PCRX
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PharmaCorp Rx Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of C$0.00 Mil mean?
PharmaCorp Rx (TSXV:PCRX) has a Inventories, Work In Process of C$0.00 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on PharmaCorp Rx and its competitors.
Is PharmaCorp Rx's Inventories, Work In Process too high?
PharmaCorp Rx's current Inventories, Work In Process is C$0.00 Mil. Overall, PharmaCorp Rx has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does PharmaCorp Rx's Inventories, Work In Process compare to competitors?
PharmaCorp Rx's Inventories, Work In Process of C$0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Healthcare Providers & Services company?
A good Inventories, Work In Process depends on the Healthcare Providers & Services industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on PharmaCorp Rx and its competitors. PharmaCorp Rx's current Inventories, Work In Process is C$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PharmaCorp Rx stock overvalued right now?
PharmaCorp Rx (TSXV:PCRX) has a current Inventories, Work In Process of C$0.00 Mil. The current Inventories, Work In Process is C$0.00 Mil. PharmaCorp Rx's overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For PharmaCorp Rx (TSXV:PCRX), the current Inventories, Work In Process is C$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PharmaCorp Rx Business Description

Address 303 Wellman Lane, Suite 203, Saskatoon, SK, CAN, S7T 0J1
PharmaCorp Rx Inc operates three PharmaChoice bannered pharmacies in Canada and will continue to acquire PharmaChoice Canada-branded pharmacies as it come to market in conjunction with its strategic alliance agreement with PharmaChoice Canada. The company will also acquire independently owned non-PharmaChoice Canada-bannered pharmacies in Canada, and thereafter, continue to operate such acquired pharmacies under a PharmaChoice Canada banner.
36GF Score

Get the complete analysis for TSXV:PCRX

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$0.50
Price